ArticleDiabetes, obesity & metabolism2017

Addition of or switch to insulin therapy in people treated with glucagon-like peptide-1 receptor agonists: A real-world study in 66 583 patients.

Olga Montvida et al.PubMed ↗Publisher ↗

No numbers read from the abstract.